chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Patient had his first shot on 7/26/22 when he was 4 years old.  He had his second shot on 8/16/22 when he was 4 years old.  He turned 5 years old, therefore he was supposed to get a monovalent 5 year old dose as his 3rd shot to complete his primary series.  This is what I ordered for his appointment.  When I arrived at pharmacy, I immediately told them when I checked in that he was under the special transition rules.  I had researched on the CDC website and consulted with my pediatrician.  But they did not believe this was true and they gave him a bivalent booster instead.  I even asked what they were giving each of us because there were 4 of us getting shots and they still did not disclose to me that they were giving patient something different than what I asked for.  Right after the shot they asked me to sign a form consenting that they changed the monovalent shot I ordered to a bivalent booster and I was shocked and did not sign because I did not consent to this.  They told me that nobody gets a third shot unless they are immunocompromised.  They did not believe me even when I showed them the CDC guidance.  They were totally unaware that 6 month to 4 year olds have a 3 shot primary series for Pfizer vaccines and they were unaware of the transition rules.  They had no right to give my son a shot that I did not order and did not consent to.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Recalled product administered
Clinical narrative: Patient received1st dose of Pfizer Pediatric dose on 10/01/2022 Lot FL2757. Product removal update on 10/25/2022 for Lot FL2757
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product lot number issue
Clinical narrative: NOT ADVERSE EVENT: - Patient was given the correct vaccine lot number FT1551 -- however box of previous lot number was scanned instead lot number FL2757 with expiration date of 9/30/22
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event. Administration Error--original manufacturer expiration date 9/30/22. Vaccine was given within extended manufacturer stability guidelines.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: EXPIRED - ERROR FROM PFIZER
Age: 51.0
Sex: M
Vaccine: COVID19-2
Symptoms: Poor quality product administered
Clinical narrative: The Moderna Bivalent vaccine was administered after a temperature excursion and the vaccine was not viable.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: On 7/27 began sneezing and horrible runny nose this happened for two days and I decided to test and tested positive for COVID-19. On day 3 I began heavy coughing and decided to go to walk in clinic. The dr prescribed Paxolovid. After 36 hours I saw an improvement in symptoms, and they completely resolved in 5 days.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired covid-19 vaccine was given to patient by error
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED PFIZERVAC COVID 19 5-11Y INJ   LOT #FL2757 ON 10/9/2022 ACCECTED LOT # FL2757 EXPIERD  9/30/2022 WITH THE MANUFACTURER DATA TO SUPPORT THE STABILITY AND EFFICACY TILL 10/19/2022 NO REACTION HAPPEND
Age: 62.0
Sex: F
Vaccine: FLUR4
Symptoms: Erythema, Inflammation, Local reaction, Rash macular, Skin warm
Clinical narrative: local reaction with inflammation, redness, warmth and splotchy in appearance.
Age: 76.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Malaise
Clinical narrative: Patient says she has felt very unwell since having the vaccine and that her joints were extremely painful. She is progressively improving however.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The products expiration was 09/30 per lot number but the actual expiration is 10/19/22. Information has been received from the manufacturer indicating that stability data supports the use of this product through Oct. 19.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event but we received a recall about the expiration date after the administration of the vaccine.  It supposedly expired on 9/30/22 but we were not notified of the recall with the expiration date until 10/14/2022.  Our company required us to let VAERS know.  Our company got with Pfizer and the medication was believed to be still effective and a revaccination was not needed.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: NOT ADVERSE EVENT:  Patient was given the correct vaccine NDC 59267-1055-04 lot number FT1551 -- however box of previous lot number was scanned instead lot number FL2757 with expiration date of 9/30/22
Age: 48.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Wrong product administered
Clinical narrative: Patient came in for a Covid vaccine and stated to the CMA administering the vaccine "I have never had any covid vaccines before.' The vaccine administered was Moderna Bi-valent as his first dose as primary vaccine.  The CMA reported that patient had told her this and I explained that the wrong vaccine had been given and she stated "I thought this was the only Moderna vaccine we were giving now."  I immediately contacted out vaccine coordinator to find out what action we needed to take. She explained to me that he needed a Moderna monovalent dose immediately. I called the patient and explained to him what had happened and advised him to come in ASAP for this monovalent dose because the wrong vaccine was given, I explained to him that he received a booster dose instead of a primary dose and that it should not hurt him it just would not be effective for him. none
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Atrioventricular block first degree, COVID-19, Cerebral ventricle dilatation, Chest X-ray normal
Clinical narrative: Pt COVID + 10/16/22 - Received Pfizer vaccines x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 18, 2022   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dizziness [R42] Weakness [R53.1] Chest pain, unspecified type [R07.9] COVID-19 [U07.1]   HOSPITAL COURSE:  67 y.o. male with past medical history significant for coronary artery disease, hypertension, hyperlipidemia, paroxysmal atrial fibrillation, hyperlipidemia, right hip arthroplasty and on March 22. Patient presented to emergency department with approximately 1 week of fatigue, malaise, weakness, chest discomfort, shortness of breath.  Upon arrival to emergency department patient was hemodynamically stable.  Labs unremarkable except for mild hyponatremia.  He did test positive for COVID.  Due to vague complaints of chest pain, troponin was obtained and was normal.  EKG revealed sinus rhythm with first-degree AV block, known left bundle branch block.  Chest x-ray is negative for acute process.  CT head is negative for acute process, there is mild disproportionate ventriculomegaly.  Patient was unable to stand or walk when evaluated in the emergency department and thus admitted for further care.  Initially patient had relative hypotension and home Toprol-XL dose was decreased to 25 mg daily and Cozaar Lasix held.  Blood pressures improved Cozaar  restarted.  Patient remained on room air.  Decadron was discontinued secondary to this.  PT OT consulted and recommending home.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest discomfort, Chest pain, Computerised tomogram head abnormal, Dizziness, Dyspnoea
Clinical narrative: Pt COVID + 10/16/22 - Received Pfizer vaccines x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 18, 2022   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dizziness [R42] Weakness [R53.1] Chest pain, unspecified type [R07.9] COVID-19 [U07.1]   HOSPITAL COURSE:  67 y.o. male with past medical history significant for coronary artery disease, hypertension, hyperlipidemia, paroxysmal atrial fibrillation, hyperlipidemia, right hip arthroplasty and on March 22. Patient presented to emergency department with approximately 1 week of fatigue, malaise, weakness, chest discomfort, shortness of breath.  Upon arrival to emergency department patient was hemodynamically stable.  Labs unremarkable except for mild hyponatremia.  He did test positive for COVID.  Due to vague complaints of chest pain, troponin was obtained and was normal.  EKG revealed sinus rhythm with first-degree AV block, known left bundle branch block.  Chest x-ray is negative for acute process.  CT head is negative for acute process, there is mild disproportionate ventriculomegaly.  Patient was unable to stand or walk when evaluated in the emergency department and thus admitted for further care.  Initially patient had relative hypotension and home Toprol-XL dose was decreased to 25 mg daily and Cozaar Lasix held.  Blood pressures improved Cozaar  restarted.  Patient remained on room air.  Decadron was discontinued secondary to this.  PT OT consulted and recommending home.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dysstasia, Electrocardiogram abnormal, Fatigue, Gait inability, Hyponatraemia
Clinical narrative: Pt COVID + 10/16/22 - Received Pfizer vaccines x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 18, 2022   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dizziness [R42] Weakness [R53.1] Chest pain, unspecified type [R07.9] COVID-19 [U07.1]   HOSPITAL COURSE:  67 y.o. male with past medical history significant for coronary artery disease, hypertension, hyperlipidemia, paroxysmal atrial fibrillation, hyperlipidemia, right hip arthroplasty and on March 22. Patient presented to emergency department with approximately 1 week of fatigue, malaise, weakness, chest discomfort, shortness of breath.  Upon arrival to emergency department patient was hemodynamically stable.  Labs unremarkable except for mild hyponatremia.  He did test positive for COVID.  Due to vague complaints of chest pain, troponin was obtained and was normal.  EKG revealed sinus rhythm with first-degree AV block, known left bundle branch block.  Chest x-ray is negative for acute process.  CT head is negative for acute process, there is mild disproportionate ventriculomegaly.  Patient was unable to stand or walk when evaluated in the emergency department and thus admitted for further care.  Initially patient had relative hypotension and home Toprol-XL dose was decreased to 25 mg daily and Cozaar Lasix held.  Blood pressures improved Cozaar  restarted.  Patient remained on room air.  Decadron was discontinued secondary to this.  PT OT consulted and recommending home.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Laboratory test abnormal, Malaise, SARS-CoV-2 test positive, Troponin normal
Clinical narrative: Pt COVID + 10/16/22 - Received Pfizer vaccines x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/16/2022 Discharge Date: Oct 18, 2022   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dizziness [R42] Weakness [R53.1] Chest pain, unspecified type [R07.9] COVID-19 [U07.1]   HOSPITAL COURSE:  67 y.o. male with past medical history significant for coronary artery disease, hypertension, hyperlipidemia, paroxysmal atrial fibrillation, hyperlipidemia, right hip arthroplasty and on March 22. Patient presented to emergency department with approximately 1 week of fatigue, malaise, weakness, chest discomfort, shortness of breath.  Upon arrival to emergency department patient was hemodynamically stable.  Labs unremarkable except for mild hyponatremia.  He did test positive for COVID.  Due to vague complaints of chest pain, troponin was obtained and was normal.  EKG revealed sinus rhythm with first-degree AV block, known left bundle branch block.  Chest x-ray is negative for acute process.  CT head is negative for acute process, there is mild disproportionate ventriculomegaly.  Patient was unable to stand or walk when evaluated in the emergency department and thus admitted for further care.  Initially patient had relative hypotension and home Toprol-XL dose was decreased to 25 mg daily and Cozaar Lasix held.  Blood pressures improved Cozaar  restarted.  Patient remained on room air.  Decadron was discontinued secondary to this.  PT OT consulted and recommending home.
Age: 77.0
Sex: M
Vaccine: TD
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccinated too early
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test normal, Eye haemorrhage, Fear, Haemorrhage subcutaneous
Clinical narrative: She got her vaccine, no problems, and then about 5-7 days later she started to get little blood spots on her skin, on the inside of her forearms and her upper chest.  That group would disappear and would get another group.  Then in late January of 2022 she started to get eye hemorrhages, which she is still continuing to have.  The blood spots under her arm skin and chest have died down some, but she gets the eye hemorrhages pretty constantly.  She went to her eye doctor and he gave her a thorough exam, could not find any reason in her eyes why it was happening, and was told to go to her PCP.  She had had a phone consultation and in April of 2022 she had thorough blood tests done which did not show anything there.  She was told that she had to wait out the hemorrhages on her eyes and there are activities that she does not do to make them worse.  She will not lift anything over a certain weights, and are a lot of things on the internet to do or not to do based on the hemorrhages.  She can just be sitting in a chair and when she gets up she can get a hemorrhage.  Sometimes the entire white of her eye is blood red.  Other than that there is nothing that can be done about it.  She gets them very frequently, has had 3 in a row over the past month or month and half.  She does have an eye drop that she just bought that she is going to use.  The eye doctors did give her some eye drops and she did have a reaction to those, but has bought a more natural kind.  This concerns as the information on line says that if you have more than 2 of eye hemorrhages in a year it is a concern, and she has had so many this year that she is worried.  She does have macular degeneration and has a very mild amount of it.  She is afraid to get any boosters due to this reaction.    She was trying to research on her own and did not find much about bleeding in eyes.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Ocular hyperaemia
Clinical narrative: She got her vaccine, no problems, and then about 5-7 days later she started to get little blood spots on her skin, on the inside of her forearms and her upper chest.  That group would disappear and would get another group.  Then in late January of 2022 she started to get eye hemorrhages, which she is still continuing to have.  The blood spots under her arm skin and chest have died down some, but she gets the eye hemorrhages pretty constantly.  She went to her eye doctor and he gave her a thorough exam, could not find any reason in her eyes why it was happening, and was told to go to her PCP.  She had had a phone consultation and in April of 2022 she had thorough blood tests done which did not show anything there.  She was told that she had to wait out the hemorrhages on her eyes and there are activities that she does not do to make them worse.  She will not lift anything over a certain weights, and are a lot of things on the internet to do or not to do based on the hemorrhages.  She can just be sitting in a chair and when she gets up she can get a hemorrhage.  Sometimes the entire white of her eye is blood red.  Other than that there is nothing that can be done about it.  She gets them very frequently, has had 3 in a row over the past month or month and half.  She does have an eye drop that she just bought that she is going to use.  The eye doctors did give her some eye drops and she did have a reaction to those, but has bought a more natural kind.  This concerns as the information on line says that if you have more than 2 of eye hemorrhages in a year it is a concern, and she has had so many this year that she is worried.  She does have macular degeneration and has a very mild amount of it.  She is afraid to get any boosters due to this reaction.    She was trying to research on her own and did not find much about bleeding in eyes.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer-BioNTech covid-19 pediatric 5-11 vaccine was administered after expiration of vaccine. Recall of vaccine issued on 10/12/2022 while vaccine was given on 10/01/22
Age: 1.75
Sex: F
Vaccine: COVID19
Symptoms: Cough, Croup infectious, Pyrexia, Wheezing
Clinical narrative: Agency woke up with a fever of 102 degrees Fahrenheit on 10/20/22 along with cough and wheezing. She was taken to urgent care the following day and was diagnosed with croup and treated with oral dexamethasone.  I don?t believe this is an adverse reaction from the vaccine. She just got sick with a virus from daycare that caused her croup.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Influenza like illness, Nasopharyngitis, Peripheral swelling, SARS-CoV-2 test positive
Clinical narrative: I got a cold after we docked from a cruise, and I tested on the 9th and the 13th, and they were both negative. I thought I just had a common cold, but my left leg started swelling on the 15th. I had something like varicose veins up my shin. When I got off the ship, I tested positive one the 22nd and was give PAXLOVID. The treatment did help the flu like symptoms, but I still have swelling in my lower leg. I went to my doctor, and they didn't think so but to be safe they are going to order some tests.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Varicose vein
Clinical narrative: I got a cold after we docked from a cruise, and I tested on the 9th and the 13th, and they were both negative. I thought I just had a common cold, but my left leg started swelling on the 15th. I had something like varicose veins up my shin. When I got off the ship, I tested positive one the 22nd and was give PAXLOVID. The treatment did help the flu like symptoms, but I still have swelling in my lower leg. I went to my doctor, and they didn't think so but to be safe they are going to order some tests.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient presented to the clinic visit for COVID-19 booster (order placed). Per report, clinic has just received a new shipment of Pfizer COVID-19 booster, but with its Gray cap, it looks just like the monovalent version for the primary series. RN administered the vaccine and discharged patient. Upon entering the information into the system, warning fired for the incorrect product (NDC 59267-1025-1). RN notified manager, and both of them confirmed that they have just given patient the monovalent rather than the bivalent vaccine.  Provider notified. Patient was informed about the error.  No adverse event noted otherwise.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Information has been received from the manufacturer indicating that stability data supports. Product might have possibly expired  09/30/2022
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Syncope
Clinical narrative: Pt had a syncopal episode after vaccination with HPV.  Paramedics called and she was assessed by providers at the clinic.  Pt stable and parent took her home.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Myalgia, Pyrexia
Clinical narrative: I tested positive for Covid 19 on August 29,2022 I experienced Fatigue, Fever of 102.0, muscle aches, sneezing, cough. I was taking Tylenol and was prescribed Paxlovid for my symptoms.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: I tested positive for Covid 19 on August 29,2022 I experienced Fatigue, Fever of 102.0, muscle aches, sneezing, cough. I was taking Tylenol and was prescribed Paxlovid for my symptoms.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer on 10/12/2022 sent for a removal of Lot# FL2757 due to expiration date of 9/30/2022. Dose was given before email for removal came through. Pfizer indicated that the stability data supports the use of the product through 10/19/2022. No revaccination or patient notification required.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product expiration date issue, Recalled product administered
Clinical narrative: There was no actual adverse event reported, the immunization was administered during a recall of a lot number that had a shorted expiration date.  It was later stated by the mfg that the vaccine was still safe to use, the patient did not need to repeat series and we did not need to notify the patient....but we are submitting this for record purposes only.
Age: 65.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Muscle pain in the left shoulder that just gets worse ever since injection
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: stability is confirmed till october 19 but initial expiration was sept 30 for this lot number pediatric pfizer
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: stability is confirmed till october 19 but initial expiration was sept 30 for this lot number pediatric pfizer
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: There was no actual adverse event reported, the immunization was administered during a recall of a lot number that had a shorted expiration date.  It was later stated by an agency that the vaccine was still safe to use, the patient did not need to repeat series, and we did not need to notify the patient....but we are submitting this for record purposes only.
Age: 73.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Amnesia, Feeling abnormal
Clinical narrative: memory loss, mental fog.
Age: 73.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Aphasia, Arthralgia, Cognitive disorder, Memory impairment, Myalgia
Clinical narrative: memory loss, mental fog.
Age: 73.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Pneumonia, Speech disorder, Weight decreased
Clinical narrative: memory loss, mental fog.
Age: 3.0
Sex: M
Vaccine: FLU4
Symptoms: Insomnia, Pain, Pyrexia
Clinical narrative: On 09/30/22, Mother brought her 3-year-old son in for a flu vaccine. On the consent form, mother checked as her son had Guillain-Barre syndrome (GBS). Pharmacist asked when GBS was given and mother said it was a while ago and son is now fine. Pharmacist asked between the time of the GBS and now did the son receive any vaccines and mother said yes. Pharmacist asked if the son was okay with those vaccines and the mother said yes.  Pharmacist also asked if this is the first time the son received the flu shot, mother said yes. Pharmacist then recommended her son to get the flu at a doctor instead, and the mother said no as preferring the pharmacy.  Pharmacist checked Drug Facts and Comparison referencing that patient with history of GBS can receive flu vaccines. Fluzone Quad was given to patient on 09/30/22 around 3:00PM.  Mother came in on 10/25/22 having conversation with manager on duty. Mother reported that her son had been having adverse effects of fever, body ache, and unable to sleep the past 3 weeks. She had to stay at home to take care of her son because daycare would not. Mother said she took her son to a doctor and the doctor told her that the son shouldn?t even get the flu shot. Mother stated that she is talking to a lawyer about the case.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Poor quality product administered
Clinical narrative: The Moderna Bivalent vaccine was administered after a temperature excursion and the vaccine was not viable.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Headache, Injection site pain, Lip swelling, Pharyngeal swelling, Streptococcus test negative
Clinical narrative: Went to bed with head ache on 09/12/2022 and on 0913/2022  woke up with lips swollen and throat feeling swollen.  Pain at injection site. Mom took patient to ER.
Age: 22.0
Sex: U
Vaccine: COVID19-2
Symptoms: Feeling abnormal, Headache, Vertigo
Clinical narrative: Vaccines given at appt 10/21/22, the next morning pt developed vertigo symptoms, headache and brain fog,  other symptoms were mild and have since resolved, vertigo worsened throughout the day and has persisted. Brain fog will happen for 10-15 min at a time intermittently throughout the day
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: MANUFACTURE EXPIRATION DATE OF 9/30/22. INFORMATION RECEIVED FROM MANUFACTURE INDICATING THAT STABILITY DATA SUPPORTS THE USE OF THIS PRODUCT THROUGH OCT 19
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Feeling abnormal, Headache, Oropharyngeal pain
Clinical narrative: I had sore throat and headache for the first two days. Then I had congestion and fatigue for the next 5 days. Then the congestion started to break after a week, and all the symptoms started to gradually reduce after week. I took over the counter cold medication, acetaminophen, and ibuprofen. I also had head fog.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: I had sore throat and headache for the first two days. Then I had congestion and fatigue for the next 5 days. Then the congestion started to break after a week, and all the symptoms started to gradually reduce after week. I took over the counter cold medication, acetaminophen, and ibuprofen. I also had head fog.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram cerebral, Arteriogram carotid, Nausea, Scan with contrast, Vertigo
Clinical narrative: Vertigo/Nausea; Treatment at Emergency room; Treated with Meclizine and ondansetron
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired but stability was supported by pfizer through 10/19/2022
Age: 1.0
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered
Clinical narrative: I year old given both Varivax and MMR-V ProQuad
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Anal incontinence, Asthenia, Blood magnesium normal, COVID-19, Chest X-ray normal
Clinical narrative: COVID + 10/16/22  - Vaccinated with pfizer x4 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge:  Admission Date: 10/16/2022 Discharge Date: 10/19/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dehydration [E86.0] Hypokalemia [E87.6] Generalized weakness [R53.1] Diarrhea, unspecified type [R19.7] COVID-19 virus detected [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 77 y.o. female who presents to hospital with weakness.  Patient reports developing cough approximately 4 days ago.  She began to be increasingly weak at this time with poor appetite and diarrhea.  She was unable to get off of her couch and was found in urine and stool at her home.  She was brought to the emergency department for evaluation.  She was afebrile, hemodynamically stable and not hypoxic.  Lab evaluation revealed a hypokalemia with normal magnesium level.  LFTs were elevated an EKG showed a significantly prolonged QT interval.  She denied of any nausea vomiting in the emergency department.  She was cleaned up by the nursing staff and bolused with IV fluids and given oral and IV potassium.  COVID testing was found to be positive and chest x-ray was negative.  Because of her weakness and severe electrolyte deficiency she was referred to the hospital for further evaluation and care.   Patient was given fluids and potassium was replaced.  The following day her electrolytes were stable but she remained very weak.  She was evaluated by Physical and Occupational therapy and felt to be a candidate for subacute rehab.  Patient was initially resistant to the idea of rehab however we did re-evaluate her for potential discharge home with home health therapy and she was unable to participate enough to make this option viable.  Care management found a COVID bed for her at hospital and she was subsequently discharged there to undergo physical therapy in a subacute rehab environment.  Her COVID symptoms never presented.  Her mild transaminitis is resolving.  We are going to discontinue her statin therapy at this point.  She was seen on the day of discharge doing well and discharged to assured in subacute rehab facility in stable condition
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dehydration, Diarrhoea, Electrocardiogram QT prolonged
Clinical narrative: COVID + 10/16/22  - Vaccinated with pfizer x4 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge:  Admission Date: 10/16/2022 Discharge Date: 10/19/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dehydration [E86.0] Hypokalemia [E87.6] Generalized weakness [R53.1] Diarrhea, unspecified type [R19.7] COVID-19 virus detected [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 77 y.o. female who presents to hospital with weakness.  Patient reports developing cough approximately 4 days ago.  She began to be increasingly weak at this time with poor appetite and diarrhea.  She was unable to get off of her couch and was found in urine and stool at her home.  She was brought to the emergency department for evaluation.  She was afebrile, hemodynamically stable and not hypoxic.  Lab evaluation revealed a hypokalemia with normal magnesium level.  LFTs were elevated an EKG showed a significantly prolonged QT interval.  She denied of any nausea vomiting in the emergency department.  She was cleaned up by the nursing staff and bolused with IV fluids and given oral and IV potassium.  COVID testing was found to be positive and chest x-ray was negative.  Because of her weakness and severe electrolyte deficiency she was referred to the hospital for further evaluation and care.   Patient was given fluids and potassium was replaced.  The following day her electrolytes were stable but she remained very weak.  She was evaluated by Physical and Occupational therapy and felt to be a candidate for subacute rehab.  Patient was initially resistant to the idea of rehab however we did re-evaluate her for potential discharge home with home health therapy and she was unable to participate enough to make this option viable.  Care management found a COVID bed for her at hospital and she was subsequently discharged there to undergo physical therapy in a subacute rehab environment.  Her COVID symptoms never presented.  Her mild transaminitis is resolving.  We are going to discontinue her statin therapy at this point.  She was seen on the day of discharge doing well and discharged to assured in subacute rehab facility in stable condition
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Electrolyte imbalance, Hypertransaminasaemia, Hypokalaemia, Laboratory test abnormal, Liver function test increased
Clinical narrative: COVID + 10/16/22  - Vaccinated with pfizer x4 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge:  Admission Date: 10/16/2022 Discharge Date: 10/19/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dehydration [E86.0] Hypokalemia [E87.6] Generalized weakness [R53.1] Diarrhea, unspecified type [R19.7] COVID-19 virus detected [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 77 y.o. female who presents to hospital with weakness.  Patient reports developing cough approximately 4 days ago.  She began to be increasingly weak at this time with poor appetite and diarrhea.  She was unable to get off of her couch and was found in urine and stool at her home.  She was brought to the emergency department for evaluation.  She was afebrile, hemodynamically stable and not hypoxic.  Lab evaluation revealed a hypokalemia with normal magnesium level.  LFTs were elevated an EKG showed a significantly prolonged QT interval.  She denied of any nausea vomiting in the emergency department.  She was cleaned up by the nursing staff and bolused with IV fluids and given oral and IV potassium.  COVID testing was found to be positive and chest x-ray was negative.  Because of her weakness and severe electrolyte deficiency she was referred to the hospital for further evaluation and care.   Patient was given fluids and potassium was replaced.  The following day her electrolytes were stable but she remained very weak.  She was evaluated by Physical and Occupational therapy and felt to be a candidate for subacute rehab.  Patient was initially resistant to the idea of rehab however we did re-evaluate her for potential discharge home with home health therapy and she was unable to participate enough to make this option viable.  Care management found a COVID bed for her at hospital and she was subsequently discharged there to undergo physical therapy in a subacute rehab environment.  Her COVID symptoms never presented.  Her mild transaminitis is resolving.  We are going to discontinue her statin therapy at this point.  She was seen on the day of discharge doing well and discharged to assured in subacute rehab facility in stable condition
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, SARS-CoV-2 test positive, Urinary incontinence
Clinical narrative: COVID + 10/16/22  - Vaccinated with pfizer x4 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge:  Admission Date: 10/16/2022 Discharge Date: 10/19/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dehydration [E86.0] Hypokalemia [E87.6] Generalized weakness [R53.1] Diarrhea, unspecified type [R19.7] COVID-19 virus detected [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 77 y.o. female who presents to hospital with weakness.  Patient reports developing cough approximately 4 days ago.  She began to be increasingly weak at this time with poor appetite and diarrhea.  She was unable to get off of her couch and was found in urine and stool at her home.  She was brought to the emergency department for evaluation.  She was afebrile, hemodynamically stable and not hypoxic.  Lab evaluation revealed a hypokalemia with normal magnesium level.  LFTs were elevated an EKG showed a significantly prolonged QT interval.  She denied of any nausea vomiting in the emergency department.  She was cleaned up by the nursing staff and bolused with IV fluids and given oral and IV potassium.  COVID testing was found to be positive and chest x-ray was negative.  Because of her weakness and severe electrolyte deficiency she was referred to the hospital for further evaluation and care.   Patient was given fluids and potassium was replaced.  The following day her electrolytes were stable but she remained very weak.  She was evaluated by Physical and Occupational therapy and felt to be a candidate for subacute rehab.  Patient was initially resistant to the idea of rehab however we did re-evaluate her for potential discharge home with home health therapy and she was unable to participate enough to make this option viable.  Care management found a COVID bed for her at hospital and she was subsequently discharged there to undergo physical therapy in a subacute rehab environment.  Her COVID symptoms never presented.  Her mild transaminitis is resolving.  We are going to discontinue her statin therapy at this point.  She was seen on the day of discharge doing well and discharged to assured in subacute rehab facility in stable condition
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: The Moderna Bivalent vaccine was administered after a temperature excursion and the vaccine was not viable.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Electrocardiogram, Feeling abnormal, Heart rate increased, Oropharyngeal pain
Clinical narrative: Very rapid heart beats when working outside on the swimming pole install and I checked my heart beat and it was 150, 170 at the ER it was 165 170. This was 6 months after the vaccine. They gave me medication to bring the rate down. I was placed on metoprolol. Then after that I followed up with my Cardiologist and Physician and I was told it's possible that it could be from having COVID-19. I had COVID-19 on the 14th of June. One night I felt off and then had a sore throat the next day and then nothing else ready.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Very rapid heart beats when working outside on the swimming pole install and I checked my heart beat and it was 150, 170 at the ER it was 165 170. This was 6 months after the vaccine. They gave me medication to bring the rate down. I was placed on metoprolol. Then after that I followed up with my Cardiologist and Physician and I was told it's possible that it could be from having COVID-19. I had COVID-19 on the 14th of June. One night I felt off and then had a sore throat the next day and then nothing else ready.
Age: 41.0
Sex: F
Vaccine: HPV9
Symptoms: Pruritus
Clinical narrative: She got her vaccine, there was no immediate reaction.  The next morning her hands itched really bad.  That evening her feet and toes itched, and has been continuous every evening and every morning since.  They itch in between the digits and on the palms of her hands and soles of her feet.  She has not taken anything for the reaction.  She has not talked to anybody regarding the reaction, and is going to call her PCP for this.
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Disorientation, Dysphonia, Flushing
Clinical narrative: I'm on day 5 of things going on. I might have had some sniffles, but I did not think twice about it until I got the positive test on Friday the October 22th. On Sunday it lingered, I tried staying hydrate and around 2:00 pm I became flushed in my cheeks and postnasal drip started. This was on October 23rd. I took a COVID-19 test on the Sunday and Saturday my throat. I have not seen my doctor in person, but I called my doctor, and he prescribed the antivirals and told me to keep track of my oxygen levels. I had my first dose last night. I felt I was slightly improving prior to taking it and there has not been significant change in symptoms. I have had body aches and a fever but after the first 18 hours I no longer have a fever. Last night it was at 101.0, I still have postnasal throat and congestion in the back of my nose, a hoarse voice and throat discomfort. I occasionally feel like I can't think as well, and I have a disoriented type feeling. It made me feel silly, but it lasted about 10 minutes and went away. I have an occasional light cough due to the postnasal drip.
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasal congestion, Oropharyngeal discomfort, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: I'm on day 5 of things going on. I might have had some sniffles, but I did not think twice about it until I got the positive test on Friday the October 22th. On Sunday it lingered, I tried staying hydrate and around 2:00 pm I became flushed in my cheeks and postnasal drip started. This was on October 23rd. I took a COVID-19 test on the Sunday and Saturday my throat. I have not seen my doctor in person, but I called my doctor, and he prescribed the antivirals and told me to keep track of my oxygen levels. I had my first dose last night. I felt I was slightly improving prior to taking it and there has not been significant change in symptoms. I have had body aches and a fever but after the first 18 hours I no longer have a fever. Last night it was at 101.0, I still have postnasal throat and congestion in the back of my nose, a hoarse voice and throat discomfort. I occasionally feel like I can't think as well, and I have a disoriented type feeling. It made me feel silly, but it lasted about 10 minutes and went away. I have an occasional light cough due to the postnasal drip.
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Thinking abnormal, Upper-airway cough syndrome
Clinical narrative: I'm on day 5 of things going on. I might have had some sniffles, but I did not think twice about it until I got the positive test on Friday the October 22th. On Sunday it lingered, I tried staying hydrate and around 2:00 pm I became flushed in my cheeks and postnasal drip started. This was on October 23rd. I took a COVID-19 test on the Sunday and Saturday my throat. I have not seen my doctor in person, but I called my doctor, and he prescribed the antivirals and told me to keep track of my oxygen levels. I had my first dose last night. I felt I was slightly improving prior to taking it and there has not been significant change in symptoms. I have had body aches and a fever but after the first 18 hours I no longer have a fever. Last night it was at 101.0, I still have postnasal throat and congestion in the back of my nose, a hoarse voice and throat discomfort. I occasionally feel like I can't think as well, and I have a disoriented type feeling. It made me feel silly, but it lasted about 10 minutes and went away. I have an occasional light cough due to the postnasal drip.
Age: 23.0
Sex: M
Vaccine: COVID19-2
Symptoms: Herpes zoster, Neck pain, Rash
Clinical narrative: Neck pain and rash on left side shoulder/chest. Shingles. Developed on Oct 23rd. Reached out to Doctor on 10/25 and received prescription. Currently taking prescription Valacyclovir 1mg every 8 hours for 7 days. Never had chicken pox, but did have the vaccine.
Age: 58.0
Sex: F
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Immediately, EE went to PCP and taking Advil and RX NSAIDS EE states it is not better . EE went to her her PCP who put her on RX NSAIDS . EE states it is not getting better. Appointment made with Occupational medicine for evaluation.
Age: 58.0
Sex: F
Vaccine: FLU4, UNK
Symptoms: Peripheral swelling, Skin discolouration
Clinical narrative: Employee reports arm swelling and turning purple around shoulder. Felt symptomatic about an hour after the flu shot was given. No treatment needed, 5 days later, arm appears normal. No bruising, swelling, discoloration. Employee's job has not been affected due to the event. Employee did not request to see a provider. Employee requests not to get that vaccination again.
Age: 58.0
Sex: F
Vaccine: FLU4, UNK
Symptoms: Heart rate increased, Hypertension
Clinical narrative: Employee reports arm swelling and turning purple around shoulder. Felt symptomatic about an hour after the flu shot was given. No treatment needed, 5 days later, arm appears normal. No bruising, swelling, discoloration. Employee's job has not been affected due to the event. Employee did not request to see a provider. Employee requests not to get that vaccination again.
Age: 76.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: I had my vaccination on 04/25/2022. Within 6 hours of vaccination I started to experience grogginess headache fatigue fever cough sore throat. I had body aches and tried to sleep it off. I took a COVID-19 test 06/28/2022 which was positive. I contacted the pharmacy for a telehealth visit. I was prescribed something for the cough. The cough is still present on 10/25/2022.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive, Somnolence
Clinical narrative: I had my vaccination on 04/25/2022. Within 6 hours of vaccination I started to experience grogginess headache fatigue fever cough sore throat. I had body aches and tried to sleep it off. I took a COVID-19 test 06/28/2022 which was positive. I contacted the pharmacy for a telehealth visit. I was prescribed something for the cough. The cough is still present on 10/25/2022.
Age: 61.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Arrhythmia, Heart rate increased, Palpitations
Clinical narrative: Patient received the updated booster vaccination and 3-4 days later began experiencing heart palpitations/ rapid heart rate. He reported to his primary care physician where it was discovered that he had a heart arrhythmia. Patient has since been referred to a cardiologist for further care.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aortic arteriosclerosis, Blood creatinine normal, Blood electrolytes normal, Blood glucose normal, Blood magnesium normal
Clinical narrative: Heart palpitations/fluttering and extreme lightheadedness 26 hours post injection and again 44 hours after injection. Patient was advised to go to ER. EKG, blood work and chest x-ray showed no obvious cause of events - other than elevated BP. No further episodes experienced other than continued rapid pulse and fluctuating BP as of this reporting time, 5 days post injection.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood pressure fluctuation, Blood pressure increased, Blood test, Blood urea normal, Cardiac flutter
Clinical narrative: Heart palpitations/fluttering and extreme lightheadedness 26 hours post injection and again 44 hours after injection. Patient was advised to go to ER. EKG, blood work and chest x-ray showed no obvious cause of events - other than elevated BP. No further episodes experienced other than continued rapid pulse and fluctuating BP as of this reporting time, 5 days post injection.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest X-ray abnormal, Differential white blood cell count normal, Dizziness, Electrocardiogram normal, Full blood count normal
Clinical narrative: Heart palpitations/fluttering and extreme lightheadedness 26 hours post injection and again 44 hours after injection. Patient was advised to go to ER. EKG, blood work and chest x-ray showed no obvious cause of events - other than elevated BP. No further episodes experienced other than continued rapid pulse and fluctuating BP as of this reporting time, 5 days post injection.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Heart rate increased, Palpitations, Spinal osteoarthritis
Clinical narrative: Heart palpitations/fluttering and extreme lightheadedness 26 hours post injection and again 44 hours after injection. Patient was advised to go to ER. EKG, blood work and chest x-ray showed no obvious cause of events - other than elevated BP. No further episodes experienced other than continued rapid pulse and fluctuating BP as of this reporting time, 5 days post injection.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Scheduled to receive a Tdap vaccine at school vaccine clinic by Health Department (HD) nurses. School nurse had given HD nurses of the students signed up needing the vaccine. I gave the vaccine on 10/18/22 and our secretary was entering it on Immunization Registry and saw it had been given 07/05/2022. NO adverse effects.--I did talk with school nurse regarding her process . (e-mail had been sent to all 6th graders that Tdaps were offered in the schools when HD comes to give Flu vaccines. Mother thought that meant her child needed it so she completed a form for this child. Process will change next year) I also phoned her doctor's office and he stated should not have issues. Reported this to mother. (I had already reported to just expect intensified side affects).
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Blister, Burning sensation, Pruritus, Rash erythematous, Rash vesicular
Clinical narrative: Patient presented with erythematous rash with occasional vesicular blisters over upper chest, bilateral arms, and upper back. Rash was not present on the lower body. Patient complained of itching and burning sensation.
Age: 80.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Underdose
Clinical narrative: The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022